Table 1.
Baseline descriptive characteristics by glycemic status for 5,641 women and men in the CHS.
| Women (n = 3254) | Men (n = 2387) | |||||
|---|---|---|---|---|---|---|
| DM (n = 465) | IFG (n = 1144) | No IFG or DM (n = 1645) | DM (n = 453) | IFG (n = 991) | No IFG or DM (n = 943) | |
| Black race | 139 (29.9%)† | 162 (14.2%) | 248 (15.1%) | 84 (18.5%) | 100 (10.1%)‡ | 142 (15.1%) |
| Age (years) | 72.7 (±5.7) | 72.6 (±5.5) | 72.4 (±5.3) | 72.9 (±5.2) | 73.2 (±5.6) | 73.5 (±6.1) |
| Current smoker | 50 (10.8%) | 149 (13.0%) | 213 (13.0%) | 42 (9.3%) | 105 (10.6%) | 118 (12.5%) |
| Current drinker | 122 (26.3%)† | 535 (46.9%) | 777 (47.4%) | 189 (41.8%)† | 623 (63.2%) | 572 (60.9%) |
| Oral estrogen use | 20 (4.3%)† | 102 (8.9%)† | 270 (16.4%) | NA | NA | NA |
| Calcium supplement use | 73 (15.9%)† | 273 (24.1%)† | 513 (31.5%) | 35 (7.8%) | 95 (9.7%) | 92 (9.9%) |
| Height (cm) | 159.4 (±6.3) | 158.9 (±6.4) | 158.7 (±6.1) | 173.6 (±6.8) | 172.9 (±6.6) | 173.0 (±6.5) |
| Weight (lbs) | 165.2 (±32.3)† | 154.4 (±31.2)† | 141.6 (±28.3) | 184.2 (±31.2)† | 177.2 (±26.8)† | 167.1 (±24.8) |
| BMI (kg/m2) | 29.5 (±5.4)† | 27.7 (±5.2)† | 25.5 (±4.8) | 27.7 (±4.3)† | 26.9 (±3.7)† | 25.3 (±3.3) |
| Waist circumference (cm) | 100.4 (±14.1)† | 94.1 (±14.1)† | 88.4 (±13.5) | 101.2 (±11.2)† | 98.8 (±10.0)† | 94.6 (±9.5) |
| Weight at age 50 (lbs) | 154.7 (±28.7)† | 141.2 (±23.1)† | 135.3 (±22.1) | 184.3 (±29.7)† | 172.6 (±24.1)† | 167.1 (±21.5) |
| Fasting insulin (IU/mL) | 21 (14,31)∗† | 14 (11,19)∗† | 11 (8,14)* | 17 (12,28)∗† | 14 (10,19)∗† | 11 (8,14)* |
| Walk time (s to walk 15 ft) | 6.7 (±2.7)† | 5.9 (±2.1) | 5.9 (±2.3) | 6.0 (±3.1)‡ | 5.5 (±2.0) | 5.5 (±2.2) |
| Physical activity (kcal/wk)* | 210 (0,749)∗† | 385 (28,1094)∗‡ | 495 (79,1193)* | 856 (230,1920)∗‡ | 917 (306,2166)∗‡ | 1088 (405,2407)* |
| Frequent falls | 33 (7.1%)† | 38 (3.3%) | 72 (4.4%) | 16 (3.6%) | 13 (1.3%) | 23 (2.5%) |
| Vision problem | 53 (12.4%)‡ | 83 (7.7%) | 117 (7.6%) | 18 (4.0%) | 50 (5.1%) | 55 (6.0%) |
| AAI < 0.90 | 89 (20.1%)† | 123 (11.1%) | 180 (11.2%) | 102 (23.2%)† | 129 (13.2%) | 112 (12.0%) |
| Prevalent CVD | 151 (32.5%)† | 237 (20.7%)‡ | 285 (17.3%) | 189 (41.7%)† | 285 (28.8%) | 290 (30.8%) |
| High creatinine (≥1.5 mg/dL men or ≥1.3 mg/dL women) | 37 (8.2%)‡ | 52 (4.6%) | 70 (4.3%) | 55 (12.2%) | 108 (10.9%) | 95 (10.1%) |
| eGFR <60 mL/min/ 1.73 m2 | 99 (21.9%) | 245 (21.4%) | 333 (20.2%) | 118 (26.5%)‡ | 245 (24.7%)‡ | 196 (20.8%) |
Data are means (±standard deviations) or proportions unless otherwise indicated.
*Data are medians (25th percentile, 75th percentile).
† P value <0.001. ‡ P value <0.05.